Arizona sues L'Oreal over cancer risk claims

Arizona officials filed a lawsuit on September 11, 2026, alleging L'Oreal concealed evidence that chemical hair-straightening products increase cancer risk in women, officials said.

Arizona suit accuses L'Oreal

The complaint, filed in state court, names the company and argues internal research and industry data were withheld from regulators and consumers, officials said. It seeks damages and injunctive relief that could affect marketing and sales of the products in the US.

Legal and market implications are immediate.

If the allegations survive early challenges, the case could prompt product withdrawals, additional state or federal investigations, and settlement costs; those channels could put pressure on L'Oreal's US revenue and investor sentiment, analysts have noted in similar cases.

For now, the direct financial exposure is unclear: the filing did not specify a damages amount, and company spokespeople were not cited in the complaint. Investors and portfolio managers will watch regulatory filings and any corporate statements for signs of supply-chain or sales impacts.

If standard civil-procedure timelines apply, L'Oreal would typically need to respond within 30 days; if that holds, a formal answer would be due by mid-October 2026, a near-term date for investors to monitor.